Evidence map›Paper›PMID 42033254›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Highly Efficient Mechanochromic Thermally Activated Delayed Fluorescence in the Deep Red to Near-Infrared in Copper(I) [2.2]Isoindolinophanyl-Carbene Carbazolates.

André M T Muthig, Sabyasachi Maity, Andreas Prüfer, Justin Krieger, Andrei Belyaev, Jan-Benedikt Weiß, Sebastian Henke, Benjamin Hupp, Björn Ewald, Jens Pflaum and 1 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

André M T MuthigDepartment of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Sabyasachi MaityDepartment of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Andreas PrüferDepartment of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Justin KriegerDepartment of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Andrei BelyaevDepartment of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Jan-Benedikt WeißDepartment of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Sebastian HenkeDepartment of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0003-1502-6038
Benjamin HuppDepartment of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Björn EwaldExperimental Physics VI, Julius-Maximilians University Würzburg, Würzburg, Germany.
Jens PflaumExperimental Physics VI, Julius-Maximilians University Würzburg, Würzburg, Germany.
Andreas SteffenDepartment of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.ORCID https://orcid.org/0000-0002-6952-7391

Funding

German Research Foundation
6 · The paper itself

Abstract

Low energy triplet emitters are highly relevant for the development of OLEDs and fiber optics-based IT applications, but typically suffer from nonradiative decay due to the energy gap law (EGL). Excited state deactivation can be limited by enhancing the radiative decay rate via thermally activated delayed fluorescence (TADF), bypassing spin-forbidden phosphorescence. We report on linear copper(I) complexes bearing a recently reported [2.2]isoindolinophanyl-carbene (iPC) ligand as potent excited state π-acceptor. The compounds show efficient TADF from ligand-to-ligand charge transfer (

Indexed as

carbenescoppermechanochromismNear‐IRTADF

Identifiers

PMID42033254
PMCPMC13245606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.